These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26530043)

  • 1. Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression.
    Philley JV; Kannan A; Qin W; Sauter ER; Ikebe M; Hertweck KL; Troyer DA; Semmes OJ; Dasgupta S
    J Cell Physiol; 2016 Jun; 231(6):1364-74. PubMed ID: 26530043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.
    Kawakami K; Fujita Y; Matsuda Y; Arai T; Horie K; Kameyama K; Kato T; Masunaga K; Kasuya Y; Tanaka M; Mizutani K; Deguchi T; Ito M
    BMC Cancer; 2017 May; 17(1):316. PubMed ID: 28476099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.
    Ellinger J; Müller SC; Wernert N; von Ruecker A; Bastian PJ
    BJU Int; 2008 Aug; 102(5):628-32. PubMed ID: 18410441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
    Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
    PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients.
    Gómez-Zaera M; Abril J; González L; Aguiló F; Condom E; Nadal M; Nunes V
    Mutat Res; 2006 Mar; 595(1-2):42-51. PubMed ID: 16472830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.
    Fawzy MS; Mohamed RH; Elfayoumi AR
    Med Oncol; 2015 Mar; 32(3):74. PubMed ID: 25698533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment.
    Iommarini L; Kurelac I; Capristo M; Calvaruso MA; Giorgio V; Bergamini C; Ghelli A; Nanni P; De Giovanni C; Carelli V; Fato R; Lollini PL; Rugolo M; Gasparre G; Porcelli AM
    Hum Mol Genet; 2014 Mar; 23(6):1453-66. PubMed ID: 24163135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
    Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
    Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.
    Kharmate G; Hosseini-Beheshti E; Caradec J; Chin MY; Tomlinson Guns ES
    PLoS One; 2016; 11(5):e0154967. PubMed ID: 27152724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer.
    Yu JJ; Yan T
    Aging Male; 2010 Sep; 13(3):159-65. PubMed ID: 20136572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment.
    Hosseini-Beheshti E; Choi W; Weiswald LB; Kharmate G; Ghaffari M; Roshan-Moniri M; Hassona MD; Chan L; Chin MY; Tai IT; Rennie PS; Fazli L; Tomlinson Guns ES
    Oncotarget; 2016 Mar; 7(12):14639-58. PubMed ID: 26840259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel non-neutral mitochondrial DNA mutations found in childhood acute lymphoblastic leukemia.
    Järviaho T; Hurme-Niiranen A; Soini HK; Niinimäki R; Möttönen M; Savolainen ER; Hinttala R; Harila-Saari A; Uusimaa J
    Clin Genet; 2018 Feb; 93(2):275-285. PubMed ID: 28708239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
    Arnold RS; Sun CQ; Richards JC; Grigoriev G; Coleman IM; Nelson PS; Hsieh CL; Lee JK; Xu Z; Rogatko A; Osunkoya AO; Zayzafoon M; Chung L; Petros JA
    Prostate; 2009 Jan; 69(1):1-11. PubMed ID: 18850577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes.
    Joković SM; Dobrijević Z; Kotarac N; Filipović L; Popović M; Korać A; Vuković I; Savić-Pavićević D; Brajušković G
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.
    Gasparre G; Porcelli AM; Bonora E; Pennisi LF; Toller M; Iommarini L; Ghelli A; Moretti M; Betts CM; Martinelli GN; Ceroni AR; Curcio F; Carelli V; Rugolo M; Tallini G; Romeo G
    Proc Natl Acad Sci U S A; 2007 May; 104(21):9001-6. PubMed ID: 17517629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.